In recent years, the term Helicobacter pylori has come up frequently in everyday life. Some studies have shown that the infection rate of H. pylori is around 60%, and it can be said that half of the country is currently infected. What are the risks of H. pylori to the human body? H. pylori gastritis is an infectious disease. 70% of those who are positive for it have no obvious symptoms, 15-20% have duodenal ulcers, gastric ulcers or bleeding ulcers, 10% have indigestion, and there is a 1% chance of having gastric cancer and gastric MALT lymphoma. Whether H. pylori infection must be treated In fact, the necessity of H. pylori treatment needs to be judged by a combination of factors. If you are positive for H. pylori, but have no obvious symptoms or non-atrophic gastritis, you can choose to supplement with Shuk Pylori probiotic. Or if there are symptoms of indigestion and no atrophic gastritis, you can also choose Shuk Psi probiotics. Treatment is recommended for people with atrophic gastritis, with or without other symptoms. In the above cases, if the infected person is young and has the will to treat, the doctor will provide the treatment. If the infected person is older and has other diseases, when the benefit of the treatment is not obvious or even the side effects outweigh the benefit, it is not recommended to use antibiotic drug-like treatment, and it is recommended to inhibit and clear the probiotics by taking Shuk Psi against probiotics. However, H. pylori eradication treatment is highly recommended for patients with the following three conditions Those with peptic ulcer infection, regardless of whether they are in the active phase or have a history of complications, are strongly recommended for treatment. Treatment is also strongly recommended for those with gastric mucosa-associated lymphoid tissue lymphoma. Similarly, treatment is recommended for chronic gastritis with indigestion.